W. G. BORNMANN

1.2k total citations
21 papers, 886 citations indexed

About

W. G. BORNMANN is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, W. G. BORNMANN has authored 21 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in W. G. BORNMANN's work include Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Lung Cancer Treatments and Mutations (3 papers). W. G. BORNMANN is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Lung Cancer Treatments and Mutations (3 papers). W. G. BORNMANN collaborates with scholars based in United States, Netherlands and United Kingdom. W. G. BORNMANN's co-authors include David A. Boothman, John J. Pink, Sarah M. Planchon, Philip O. Livingston, Samuel J. Danishefsky, Howard I. Scher, Kenneth O. Lloyd, Govindaswami Ragupathi, Maria Spassova and Susan F. Slovin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

W. G. BORNMANN

21 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. G. BORNMANN United States 12 547 249 186 177 128 21 886
Murray J. Towle United States 17 440 0.8× 211 0.8× 84 0.5× 509 2.9× 50 0.4× 24 1.1k
Y Uehara Japan 17 609 1.1× 81 0.3× 190 1.0× 212 1.2× 88 0.7× 23 889
Jessica Hauschild Germany 17 565 1.0× 110 0.4× 284 1.5× 185 1.0× 130 1.0× 34 1.1k
Victoria J. Spanswick United Kingdom 21 914 1.7× 267 1.1× 58 0.3× 462 2.6× 58 0.5× 39 1.3k
Jaulang Hwang Taiwan 17 594 1.1× 109 0.4× 145 0.8× 388 2.2× 69 0.5× 34 1.0k
Bruce Gomes United States 16 834 1.5× 261 1.0× 226 1.2× 267 1.5× 161 1.3× 17 1.3k
Rooha Contractor United States 14 870 1.6× 214 0.9× 120 0.6× 469 2.6× 20 0.2× 24 1.3k
Matthew Labenski United States 12 405 0.7× 200 0.8× 70 0.4× 166 0.9× 68 0.5× 20 701
Catherine E. Snider United States 14 409 0.7× 108 0.4× 320 1.7× 240 1.4× 82 0.6× 18 1.0k
Yukimasa Shiotsu Japan 22 1.1k 2.1× 88 0.4× 235 1.3× 305 1.7× 114 0.9× 47 1.8k

Countries citing papers authored by W. G. BORNMANN

Since Specialization
Citations

This map shows the geographic impact of W. G. BORNMANN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. G. BORNMANN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. G. BORNMANN more than expected).

Fields of papers citing papers by W. G. BORNMANN

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. G. BORNMANN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. G. BORNMANN. The network helps show where W. G. BORNMANN may publish in the future.

Co-authorship network of co-authors of W. G. BORNMANN

This figure shows the co-authorship network connecting the top 25 collaborators of W. G. BORNMANN. A scholar is included among the top collaborators of W. G. BORNMANN based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. G. BORNMANN. W. G. BORNMANN is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Gary, Ran Wang, Shan Sun, et al.. (2013). RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B. Oncogene. 33(18). 2385–2394. 28 indexed citations
2.
Yamaguchi, Hirohito, Chao‐Kai Chou, Ashutosh Pal, et al.. (2010). Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation. Oncogene. 29(41). 5619–5629. 25 indexed citations
3.
Robertson, Fredika M., et al.. (2009). The pan-HDAC Inhibitor Suberoylanilide Hydroxamic Acid Targets Self Renewal of Breast Cancer Stem Cells.. Cancer Research. 69(24_Supplement). 3141–3141. 2 indexed citations
4.
Ghosh, Pradip, et al.. (2008). Synthesis of N3-Substituted Thymidine Analogues for Measurement of Cellular Kinase Activity. Medicinal Chemistry. 4(5). 503–512. 3 indexed citations
5.
Zhang, W, Marina Konopleva, Vivian Ruvolo, et al.. (2008). Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway. Leukemia. 22(4). 808–818. 121 indexed citations
6.
Pal, Ashutosh, Athanasios Glekas, Mikhail Doubrovin, et al.. (2006). Molecular Imaging of EGFR Kinase Activity in Tumors with 124I-Labeled Small Molecular Tracer and Positron Emission Tomography. Molecular Imaging and Biology. 8(5). 262–277. 77 indexed citations
7.
Pal, Ashutosh, Athanasios Glekas, Mikhail Doubrovin, et al.. (2006). Molecular Imaging of EGFR Kinase Activity in Tumors with 124I-Labeled Small Molecular Tracer and Positron Emission Tomography. Molecular Imaging and Biology. 8(6). 373–373. 6 indexed citations
8.
Pal, Ashutosh, Athanasios Glekas, Mikhail Doubrovin, et al.. (2006). Molecular Imaging of EGFR Kinase Activity in Tumors with 124 I-Labeled Small Molecular. 9 indexed citations
9.
Barnes, David, Darren R. Veach, W. G. BORNMANN, et al.. (2004). Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate. Leukemia. 18(8). 1352–1356. 33 indexed citations
10.
Williams, Lawrence J., Andrzej Zatorski, Valery Kudryashov, et al.. (2000). Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: Isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens. Proceedings of the National Academy of Sciences. 97(6). 2719–2724. 36 indexed citations
11.
Slovin, Susan F., Govindaswami Ragupathi, Sucharita Adluri, et al.. (1999). Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proceedings of the National Academy of Sciences. 96(10). 5710–5715. 209 indexed citations
12.
Planchon, Sarah M., Shelly M. Wuerzberger‐Davis, John J. Pink, et al.. (1999). Bcl-2 protects against beta-lapachone-mediated caspase 3 activation and apoptosis in human myeloid leukemia (HL-60) cells.. Oncology Reports. 6(3). 485–92. 26 indexed citations
13.
Pink, John J., et al.. (1998). Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.. PubMed. 58(9). 1876–85. 108 indexed citations
14.
Kothari, Paresh J., et al.. (1997). Chemical Consequences Resulting from Multi-millicurie Preparation of 6-[18F]-Fluoro-6-deoxy-L-ascorbic Acid. Radiochimica Acta. 77(1-2). 87–89. 3 indexed citations
15.
Prochaska, Hans J., W. G. BORNMANN, Penny Baron, & Bruce Polsky. (1995). Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.. Molecular Pharmacology. 48(1). 15–20. 7 indexed citations
16.
17.
Joseph, Cecil K., Samuel D. Wright, W. G. BORNMANN, et al.. (1994). Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. Journal of Biological Chemistry. 269(26). 17606–17610. 127 indexed citations
18.
Wang, Shen, Craig A. Coburn, W. G. BORNMANN, & Samuel J. Danishefsky. (1993). ChemInform Abstract: Concise Total Syntheses of dl‐Camptothecin (I) and Related Anticancer Drugs.. ChemInform. 24(32). 1 indexed citations
19.
20.
Kuehne, Martin E., et al.. (1985). Biomimetic syntheses of indole alkaloids. 11. Syntheses of .beta.-carboline and indoloazepine intermediates. The Journal of Organic Chemistry. 50(7). 919–924. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murray J. Towle Breakdown of academic impact, for papers by Y Uehara Breakdown of academic impact, for papers by Jessica Hauschild Breakdown of academic impact, for papers by Victoria J. Spanswick Breakdown of academic impact, for papers by Jaulang Hwang Breakdown of academic impact, for papers by Bruce Gomes Breakdown of academic impact, for papers by Rooha Contractor Breakdown of academic impact, for papers by Matthew Labenski Breakdown of academic impact, for papers by Catherine E. Snider Breakdown of academic impact, for papers by Yukimasa Shiotsu
Rankless by CCL
2026